BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22446103)

  • 21. Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cells.
    Chanawong A; Hu DG; Meech R; Mackenzie PI; McKinnon RA
    Drug Metab Dispos; 2015 Jun; 43(6):889-97. PubMed ID: 25795461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
    Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ
    J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
    Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
    Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura A; Lawrence J; Berstein L; Yue W
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S61-73. PubMed ID: 16113100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
    Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
    Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
    Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
    FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.
    Alayev A; Salamon RS; Berger SM; Schwartz NS; Cuesta R; Snyder RB; Holz MK
    Oncogene; 2016 Jul; 35(27):3535-43. PubMed ID: 26522726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in hyaluronic acid degradation decreases the expression of estrogen receptor alpha in MCF7 breast cancer cell line.
    Hanoux V; Eguida J; Fleurot E; Levallet J; Bonnamy PJ
    Mol Cell Endocrinol; 2018 Nov; 476():185-197. PubMed ID: 29753772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
    Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
    J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J; Li J; Sidell N
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.
    Song RX; Chen Y; Zhang Z; Bao Y; Yue W; Wang JP; Fan P; Santen RJ
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):219-30. PubMed ID: 19815064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.
    Wang Y; Zhou D; Phung S; Masri S; Smith D; Chen S
    Mol Endocrinol; 2011 Jan; 25(1):72-82. PubMed ID: 21084382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
    Privette Vinnedge LM; Ho SM; Wikenheiser-Brokamp KA; Wells SI
    PLoS One; 2012; 7(10):e46985. PubMed ID: 23071688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.